Oxaliplatina ad Platinum Anticancer Medicamenta
Productumnomen | Oxaliplatin |
Synonyma | trans-L-Diaminocyclohexane oxalatoplatinum |
CAS Non. | 61825-94-3 |
Aspectus | White off album crystallization pulveris |
Formulae hypotheticae | C8H12N2O4Pt |
M. Pondus | 395.27 |
Consuetudinem | Pharmaceutical Grade vel Research proposito |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
OxaliplatinCas:61825-94-3 | ||
Items | Standard | Proventus |
Aspectus | Album vel paene album crystallinum pulveris | Album pulveris crystallini |
Solubilitas | Leviter in aqua solutum , in methanolo leviter solutum , in ethanolo anhydro fere insolubile . | Obsequitur |
Lepidium sativum | Spectrum specimen debet stare cum spectro relationis vexillum | A.CompliesB.Complies |
Aspectus solutionis | Solutio patet et sine colore | Obsequitur |
Acorem | Non plus quam 0.6ml ex 0.01M NaOH oportet mutare colorem indicatoris rosei | Obsequitur |
Imprimis optical rotatio | +74.5°~+78.0° | +75.9° |
Substantiae cognatae | ImpurityA: NMT0.10%ImpurityB: NMT0.10% ImpurityC: NMT0.10% Alia immunditia: NMT0.10% Summa aliarum immunditiarum: NMT0.10% (Includit immunditiam C) Summa immunditiarum: NMT0.30% | ImpurityA: 0.04% ImpurityB: 0.01%ImpurityC: 0.001% Aliae immunditiae: 0.002% Summa aliarum immunditiarum; 0.01% Summa immunditiarum: 0.03% |
immunditia D | NMT0.10% | ND |
Argenti | NMT5.0ppm | 0.08ppm |
Damnum in siccitate | NMT0.5% | 0.09% |
Assay | 98.0 ~ 102.0% (substantia arida) | 99.7% |
conclusio:Proventus ostendunt productum obsequium cum EP9.0 |
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.Epistulam tuam hic scribe et mitte nobis